refresh

トレンド企業

Trending

採用

Jobs

Editas Medicine

Editas Medicine

Editas Medicine

Genome editing company

Gene Editing

CRISPR Technology

Genomic Medicine

Clinical Research

Rare Diseases

Cambridge, Massachusetts, United States

201-500

Founded 2013 (13yrs)

Hybrid

Public

Total Funding

$300M

EDIT

$1.76

Revenue (2026)

$0

Operating Income

$0

Open Positions

0 positions

No open positions at this time

Products & Services

RE

reni-cel

Gene Therapy

IN

In Vivo Gene Editing Medicines

Gene Therapy

Leadership

CS

Charlene Stern

Executive Vice President & General Counsel

KB

Kevin Bitterman

Interim President

DRL

David R. Liu

Founder

FZ

Feng Zhang

Founder

Total Views

0

Apply Clicks

0

Mock Applicants

0

Scraps

0

Reviews

3.5

8 reviews

Work Life Balance

3.8

Compensation

3.5

Culture

3.2

Career

2.8

Management

2.3

Pros

Good benefits and compensation

Positive work environment

Interesting science and work

Cons

Poor upper management

Lack of direction and strategy changes

Management issues and poor leadership

Salary Ranges

38 data points

Director

Director

1 reports

$195,000

total / year

Base

$150,000

Stock

-

$195,000

$195,000

Interview Experience

39 interviews

Difficulty

3.4

/ 5

Duration

2-5w

Offer Rate

35%

Experience

Positive 67%

Neutral 15%

Negative 18%

Interview Process

1

Phone Screen

2

Technical Interview

3

Hiring Manager

4

Team Fit

Contact & Location